Shares of Calvin Klein-parent PVH and Illumina fall after China targets companies

Reuters
02-04
Shares of Calvin Klein-parent PVH and <a href="https://laohu8.com/S/ILMN">Illumina</a> fall after China targets companies

Feb 4 (Reuters) - Shares of Calvin Klein-owner PVH Corp PVH.N and genetic testing company Illumina ILMN.O fell in U.S. premarket trading on Tuesday after China placed the two companies on its "unreliable entity" list, making them eligible for sanctions.

Companies added to the blacklist can be subject to fines and a broad range of other sanctions, including a freeze on trade and revocation of work permits for foreign staff.

PVH had already been under scrutiny from Chinese regulators over "improper" conduct related to the Xinjiang region.

For Illumina, China accounts for about 7% of sales. Two of its Chinese rivals, MGI and BGI, were listed in a U.S. bill that aims to restrict business with several biotech companies on grounds of national security.

Shares of Intel INTC.O also fell 1% to $19.20 in premarket trading after the Financial Times reported that Chinese regulators were also looking to launch a formal probe into the chipmaker.

An influential Chinese industry group called for a security review late last year against Intel's INTC.O products sold in China.

The announcement was part of a string of measures by China in response to new U.S. tariffs on Chinese goods. China also said it was investigating Alphabet GOOGL.O.

However, Alphabet's shares edged up nearly 1%, as some of its key products, including its Google search engine, are already blocked in China and its revenue from the country represents only about 1% of its global sales.

Illumina's shares were down 4.1% at $125.71, while PVH's stock fell 2.4% to $80.49 before the opening bell.

(Reporting by Mariam Sunny and Lisa Pauline Mattackal in Bengaluru; Editing by Pooja Desai)

((Mariam.ESunny@thomsonreuters.com;))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10